Am I eligible for a clinical trial if I have Endometrial Cancer

Clinical Trial Eligibility for Endometrial Cancer

Great question! Clinical trial eligibility for endometrial cancer depends on several factors specific to your situation. Let me explain what generally determines eligibility and what you should discuss with your care team.

GENERAL FACTORS THAT AFFECT ELIGIBILITY

According to NCCN Guidelines for Uterine Neoplasms, clinical trials for endometrial cancer typically consider:

Disease Characteristics:

• Your cancer stage (early-stage vs. advanced/recurrent)
• Histology type (endometrioid, serous, clear cell, carcinosarcoma, etc.)
• Molecular/genetic features (POLE mutations, mismatch repair status, p53 status, HER2 status)
• Whether your cancer is newly diagnosed or recurrent/persistent

Patient Factors:

• Overall health and ability to tolerate treatment
• Prior treatments you've received
• Organ function (kidney, liver, heart function)
• Performance status (how well you can perform daily activities)
• Specific medical conditions or allergies

Treatment Status:

• Whether you're eligible for surgery
• Whether you've had prior chemotherapy, radiation, or immunotherapy
• Whether your disease is operable or inoperable

TYPES OF TRIALS AVAILABLE FOR ENDOMETRIAL CANCER

Based on NCCN Guidelines, active research areas include:

• Immunotherapy trials (checkpoint inhibitors like pembrolizumab, dostarlimab, durvalumab)
• Targeted therapy trials (for specific mutations like HER2, NTRK fusions, POLE mutations)
• Combination therapy trials (chemotherapy + immunotherapy, chemotherapy + targeted therapy)
• Radiation therapy trials (new techniques and approaches)
• Metabolic/supportive care trials

WHAT YOU SHOULD ASK YOUR ONCOLOGIST

To determine YOUR specific eligibility:

1. "Are there clinical trials currently open for my specific type and stage of endometrial cancer?"

   • This is the most important question—your doctor knows which trials match your exact situation

2. "What are the key eligibility criteria for trials you're recommending, and do I meet them?"

   • Ask them to explain any criteria you don't understand

3. "What molecular testing have I had done, and how might that affect trial eligibility?"

   • Your POLE status, mismatch repair status, and p53 status can open or close certain trial options

4. "What are the potential benefits and risks of the specific trial you're suggesting?"

   • Every trial has different side effect profiles and potential benefits

5. "How will trial participation affect my standard treatment plan?"

   • Some trials replace standard treatment; others add to it

6. "What happens if I'm enrolled but need to stop the trial?"

   • Understanding exit criteria is important

WHERE TO FIND TRIALS

• ClinicalTrials.gov - Search by cancer type, location, and trial status
• Your cancer center - Often has trials available on-site
• NCCN Member Institutions - Many comprehensive cancer centers have active endometrial cancer trials
• Cancer advocacy organizations - Some specialize in connecting patients with trials

IMPORTANT CONTEXT

According to NCCN Guidelines, molecular analysis is increasingly important for endometrial cancer treatment decisions. The Panel encourages comprehensive molecular profiling to help identify which patients may benefit from specific clinical trials targeting their tumor's genetic characteristics.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Your oncologist is the best resource for determining YOUR specific eligibility, as they understand your complete medical picture, test results, and treatment history.